Mechanisms of resistance to rapamycins

This publication has 95 references indexed in Scilit:

• Multiple Mechanisms Control Phosphorylation of PHAS-I in Five (S/T)P Sites That Govern Translational Repression
  Molecular and Cellular Biology, 2000
• Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
  Cell, 1998
• Osteoblastic Differentiation Is Enhanced by Rapamycin in Rat Osteoblast-like Osteosarcoma (ROS 17/2.8) Cells
  Biochemical and Biophysical Research Communications, 1998
• Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma
  Cancer, 1997
• Rapamycin Potentiates Dexamethasone-Induced Apoptosis and Inhibits JNK Activity in Lymphoblastoid Cells
  Biochemical and Biophysical Research Communications, 1997
• The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding
  Gene, 1993
• Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
  Cell, 1993
• Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
  Science, 1991
• Human brain tumor xenografts in nude mice as a chemotherapy model
  European Journal of Cancer and Clinical Oncology, 1983
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975